Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Singular Genomics Systems, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 81 | +8 |
| Shares | 40.2M | 1.42M | 37.2M | −1.61M (−4.1%) |
| Value | $100.5M | $3.54M | $74.8M | −$22.2M (−22.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 169,747 | $341.2K | 0.11% |
| Ergoteles LLC | 67,877 | $136.4K | 0.01% |
| Weil Company, Inc. | 53,202 | $106.9K | 0.05% |
| Jane Street Group, LLC | 40,610 | $81.6K | 0.00% |
| Marquette Asset Management, LLC | 36,499 | $73.4K | 0.02% |
| MetLife Investment Management | 34,353 | $69.0K | 0.00% |
| Algert Global LLC | 27,270 | $54.8K | 0.00% |
| Squarepoint Ops LLC | 25,934 | $52.1K | 0.00% |
| Tri Locum Partners LP | 16,215 | $33.0K | 0.01% |
| Millennium Management LLC | 15,360 | $31.0K | 0.00% |
| Alliancebernstein L.P. | 13,100 | $26.3K | 0.00% |
| Metropolitan Life Insurance Co | 4,051 | $8.14K | 0.00% |
| Dark Forest Capital Management LP | 3,980 | $8.00K | 0.00% |
| Point72 Middle East FZE | 1,861 | $3.74K | 0.00% |
| Newbridge Financial Services Group, Inc. | 500 | $1.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 472 | $949 | 0.00% |
| New Hampshire Trust | 414 | $832 | 0.00% |
| Glassman Wealth Services | 202 | $406 | 0.00% |
| Massmutual Trust Co FSB | 135 | $0 | 0.00% |
Sold out (11)
Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Keybank National Association | 353,815 | $885.0K |
| Victory Capital Management Inc | 60,723 | $152.0K |
| Temasek Holdings (Private) Ltd | 21,405 | $53.5K |
| Virtu Financial LLC | 13,251 | $33.0K |
| ProShare Advisors LLC | 12,134 | $30.0K |
| Balyasny Asset Management LLC | 10,511 | $26.0K |
| China Universal Asset Management Co., Ltd. | 667 | $2.00K |
| Daiwa Securities Group Inc. | 210 | $1.00K |
| Advisor Group Holdings, Inc. | 260 | $1.00K |
| Parallel Advisors, LLC | 322 | $1.00K |
| Capital Advisors, Ltd. LLC | 168 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Singular Genomics Systems, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Revelation Capital Management, LLC | 1,415,846 | $3.54M |